Anavex Life Sciences Corp (AVXL)

[Investor2014]

I am not sure we disagree.

If there is no selection on patients characteristics biomarkers, there is no precision medicine! There may be precision research, thoroughness etc.

At present there has been no selection and as you say because it appears all patients on average may benefit sufficiently well to achieve stat sig results without the need for very large trials. We don’t know for sure yet, but we will get insights to that when eventually we see about AVATAR and EXCELLENCE.

I can’t know if and when Anavex might select for patients with certain biomarkers. I can see though that slide 5 indicates so.

If Anavex are not at some point selecting on biomarkers they shine in borrowed feathers without benefiting from the increased chances of success that slide 5 is claiming. That is my point - be careful thinking we have increased chance of success because of the precision medicine claims.